Research-driven investing for India

The best time to find a company is before the institutions do.

Empirica researches Indian small and midcaps in the ₹2,000–30,000 crore band, the window where price action has started but coverage has not.

You get the full reasoning: the entry, the stop, the risks we found, and the ones we are still watching.

Most research tells you what to buy. Almost none tells you why, or when to leave.

India has no shortage of stock ideas. What it lacks is reasoning you can inspect: the working behind the call, the price that would prove it wrong, and an honest record of the ones that did.

We built Empirica the other way round. Every company we cover gets a 60 to 80 page institutional-grade report: the balance sheet, the promoter pledge, the transcript contradictions, the entry zone, the stop loss. We publish the risks before we publish the case. And when a position fails, it stays on the record.

We are not a brokerage. We earn nothing from your trades, nothing from any AMC, and nothing from volume. We are paid by readers, which means the only thing we have to sell is being right.

Read more
“We would rather be early and boring than late and loud.”

— The principles that guide every Empirica portfolio.

Three core products

The shortlist, the reasoning, and the position.

Most services hand you a name and leave you alone with it. You get the whole chain instead: the companies still on the bench, the analysis that promoted or rejected each one, and the position with its size and exit already defined.

The live watchlist

Eight to twelve companies with live charts, on the page while the work is still underway. You start from a screened shortlist in ₹2,000 to 30,000 cr marketcap territory instead of hunting for ideas alone.

The research letters

Free Newsletter: Signal teaches our framework every week. Paid Newsletter: Selection covers what entered our watchlist and why. Paid Newsletter: Positioning is the full research report. You learn to judge a call rather than simply receive one.

The model portfolio

Position sizes, entry dates, exits and stop loss levels published in paid subscription. You see what we did and the level at which we would be wrong, so you can size it against your own money instead of guessing.

The watchlist and the weekly letter are free, permanently. The reports and the portfolio are what a subscription buys.

See what each plan includes →

The Ignition Framework

Four steps, applied the same way every time.

Every company we cover goes through the same sequence. Most do not survive step two, and that is the point of having a sequence at all.

01

Price first

We screen on relative strength against the NSE 500 across 1, 3, 6 and 12 months. The market speaks before the research does.

02

Then the business

Only names that clear the screen get the fundamental work. Most fail here, and that is exactly what the step is for.

03

The governance test

Promoter pledge, transcript against filing, FII and DII holding patterns. The uncomfortable finding is usually the valuable one.

04

Entry, stop, size

A technical seven-point checklist with an explicit pass or fail, an entry zone, position sizing and stop loss at which we admit we were wrong.

Companies in the ₹2,000–30,000 crore band only. Below that, liquidity fails you. Above it, the research has already arrived.

See what is in the framework right now →

A peek inside our model portfolio

Two positions are open below with the full history visible. Paid subscribers get the full list of holdings, average prices and XIRR.

Stocks

Sample

Subscribe to unlock the full portfolio

View plans

Mutual Funds

Sample

Subscribe to unlock the full portfolio

View plans

Start free. Upgrade when you are convinced

Every plan includes the weekly Signal and the live watchlist. What changes is how much of our work you see.

Learner

Learn how to find investment ideas, position building, entry & exit strategies in the Indian markets. If you are new to the markets this is for you.

₹249 / month
  • Weekly Newsletter - Signal | Learn the framework that we use @ Empirica India
  • Access to live charts that we are tracking @ Empirica India
Choose Learner
Most popular

Investor

This plan aids you in becoming an informed investor. In addition get a monthly research report on one of the ideas in which we have been investing @Empirica India

₹499 / month
  • Monthly Newsletter - Positioning | Institutional deep dives that we create internally to advice clients @ Empirica India
  • Bi-Monthly Newsletter - Selection | Get access to watchlist additions and removals @ Empirica India
  • Weekly Newsletter - Signal | Learn the framework that we use @ Empirica India
  • Access to live charts that we are tracking @ Empirica India
  • Standard 24/7 Email Support
Choose Investor

Wealth Creator

Get full access to model portfolio @ Empirica India. This includes our position sizing, exact buy and sell dates for each investment call. This is a full package to get to know our investment strategy and execution @ Empirica India

₹999 / month
  • Get full access to model portfolio @ Empirica India.
  • 24/7 Priority support
  • Early access to new features
  • Everything in the Investor Plan
Choose Wealth Creator

Latest work

All articles →

Company deep dives, framework notes and market reads.

Empirica Signal: Q2 FY27 Earnings Update, What we purchased this week & Market Health, 12 Nov 2026
Signal 12 Nov 2026 · 4 min read

Empirica Signal: Q2 FY27 Earnings Update, What we purchased this week & Market Health, 12 Nov 2026

Two weeks ago, 13 of our portfolio companies had reported results for July to September 2026 (Q2 of the 2026–27 financial year, or Q2 FY27). Now 22 of 25 have reported, and 11 of them beat our expectations. In the last four trading days the Nifty Smallcap 250 rose about 3% and closed on Thursday above both its 10-day and 50-day averages. By our rules, that is a healthy market to put fresh money to work, and we have started: this week we added to two holdings.

Read more
Empirica Signal: Q2 FY27 earning updates for portfolio companies and market health as on 1st Nov'26
Signal 01 Nov 2026 · 4 min read

Empirica Signal: Q2 FY27 earning updates for portfolio companies and market health as on 1st Nov'26

Results season for the July to September 2026 quarter (Q2 of the 2026–27 financial year, or Q2 FY27) is in full swing. 13 of our 23 portfolio companies have reported. 6 beat our expectations, 4 met them and 3 fell short. The other 10 report in the coming weeks. At the same time, the Nifty Smallcap 250 may be turning lower again after a short pause last week. A fall towards 16,000 is possible, so we are careful with fresh money.

Read more

Weekly reports goes to members every saturday.

Join free and you get the weekly Signal, the live watchlist and the framework we use. No card, and nothing changes until you decide it should.

Create your account